SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-042491
Filing Date
2023-12-21
Accepted
2023-12-21 16:03:05
Documents
1
Period of Report
2023-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1703192576.html 4  
1 FORM 4 wk-form4_1703192576.xml 4 3881
  Complete submission text file 0001628280-23-042491.txt   5520
Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
KAPLAN GILLA (Reporting) CIK: 0001247024 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37590 | Film No.: 231505275

Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Issuer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)